Skip to main content

Table 1 Clinical characteristics of RRMS and control subjects

From: Epigenetic mechanisms shape the underlining expression regulatory mechanisms of the STAT3 in multiple sclerosis disease

Characteristics

RRMS group (n = 50)

Control group (n = 50)

Age

35.08 (19–65)

33.01 (22–51)

Gender (female/male)

36/14

31/19

EDSS

1.75 ± 0.31

NA

Disease duration

4.9 ± 1.6 (2–15 years)

NA

  1. Data are shown as mean ± SD or frequencies
  2. NA non-applicable, EDSS expanded disability status scale